Results 41 to 50 of about 122,058 (148)

Pharmacological and toxicological aspects of doping substances and the role of the sports pharmacist [PDF]

Hospital Pharmacology
Introduction: Despite the core essence of sport, athletes often turn to doping substances to advance quickly and improve performance. Doping remains a critical issue in sports, undermining fair competition and athlete integrity. Methodology: A literature
Stojanović Dunja A., Pavlović Nebojša M., Strilić David Z., Đanić Maja P.   +3 more
doaj   +1 more source

Magnesium deficiency and diuretics. [PDF]

, 1983
Longhao Tan
openalex   +1 more source

Thiazide diuretics in chronic kidney disease: Is there still a role?

, 2023
Sabrina Haroon, Matthew E. Cove
openalex   +1 more source

The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. [PDF]

, 1988
Gary E. McVeigh, D. B. Galloway, Dennis Johnston   +2 more
openalex   +1 more source

First Line Treatment of Meniere’s Disease

Journal of Lumbini Medical College, 2016
Introduction: There is no consensus on the first line medical treatment of Meniere disease to produce symptomatic improvement and slow the disease progress.
Anup Acharya, Madan Mohan Singh, Arati Shrestha   +2 more
doaj   +1 more source

Diuretics in modern nephrology

Počki, 2019
The paper considers the problem of using loop diuretics in patients with chronic kidney disease associated with cardiovascular risk, such as heart failure, hypertension, edema syndrome, including those against diabetes mellitus. Three therapeutic margins
D.D. Ivanov
doaj   +1 more source

Loop diuretics in adult intensive care patients with fluid overload: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis [PDF]

, 2022
Sine Wichmann, Marija Barbateskovic, Ning Liang, Theis Skovsgaard Itenov, Rasmus Ehrenfried Berthelsen, Jane Lindschou, Anders Perner, Christian Gluud, Morten H. Bestle   +8 more
openalex   +1 more source

Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure

ESC Heart Failure
Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure.
Shodai Kawanami, Yasuyuki Egami, Masaru Abe, Mizuki Osuga, Hiroaki Nohara, Kohei Ukita, Akito Kawamura, Koji Yasumoto, Naotaka Okamoto, Yasuharu Matsunaga‐Lee, Masamichi Yano, Masami Nishino   +11 more
doaj   +1 more source

Retrospective cohort study to evaluate the continuous use of anticholesterolemics and diuretics in patients with COVID-19

Frontiers in Medicine
PurposeThe purpose of this study is to evaluate the interference of the continuous use of drug classes in the expression of biomarkers during the first week of hospitalization and in the prognosis of patients with COVID-19.MethodsThe patients diagnosed ...
Fabrício Marcus Silva Oliveira, Mônica Maria Magalhães Caetano, Ana Raquel Viana de Godoy, Larissa Lilian de Oliveira, Juliana Vaz de Melo Mambrini, Marina Santos Rezende, Marina Pinheiro Rocha Fantini, Marina Pinheiro Rocha Fantini, Tiago Antônio De Oliveira Mendes, Nayara Ingrid Medeiros, Nayara Ingrid Medeiros, Henrique Cerqueira Guimarães, Henrique Cerqueira Guimarães, Jacqueline Araújo Fiuza, Soraya Torres Gaze   +14 more
doaj   +1 more source

Diuretics in the management of chronic heart failure: when and how [PDF]

, 2022
J. Magdy, J McVeigh, Praveen Indraratna
openalex   +1 more source